Over a decade ago, Cepheid set the standard for innovation in automated molecular diagnostics with their first system and they’ve never looked back. And now, even with the largest installed base of any molecular platform, Cepheid is constantly innovating and evolving their capabilities. Their technology has been heralded as game-changing by healthcare leaders world-wide. They envision a better way for clinical institutions of any size, from small medical clinics to high-volume reference laboratories and major hospitals, to access the power of molecular diagnostics. Their GeneXpert® System delivers fast, scalable, and accurate diagnostic results while their expanding Xpert® test menu spans multiple clinical applications such as healthcare-associated infections, sexual health, critical infectious disease, virology, and oncology.  

Mission
To enable molecular diagnostic testing of any patient specimen on a centralized or disseminated basis, thereby enabling medical providers to identify and treat diseases early, increasing opportunities to improve patients’ survival and quality of life.

Quality Policy
Cepheid is committed to providing high quality products and services that consistently meet or exceed customer expectations. The focus on quality begins at the earliest stage of product design and carries through to the end user. Individual ownership is the basis of the Cepheid quality system. Cepheid complies with applicable regulatory requirements and continues to ensure the effectiveness of the quality management system.